Biophytis S.A. (BPTSY)
USD 3.36
(0.0%)
USD 3.36
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -803 Thousand EUR | -70.67% |
| 2022 | -508.67 Thousand EUR | -38.38% |
| 2021 | -367.59 Thousand EUR | -15.16% |
| 2020 | -319.19 Thousand EUR | -8.85% |
| 2019 | -293.24 Thousand USD | -9.5% |
| 2018 | -267.8 Thousand USD | -16.39% |
| 2017 | -230.09 Thousand USD | -24.56% |
| 2016 | -184.73 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - USD | 100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q4 | -706.31 Thousand USD | 0.0% |
| 2023 FY | -868.13 Thousand EUR | -70.67% |
| 2023 Q1 | - USD | 100.0% |
| 2023 Q3 | - USD | 100.0% |
| 2023 Q2 | -162.08 Thousand USD | 0.0% |
| 2022 FY | -508.67 Thousand EUR | -38.38% |
| 2022 Q2 | -163.84 Thousand USD | 0.0% |
| 2022 Q4 | -338.42 Thousand USD | 0.0% |
| 2021 Q2 | -156.65 Thousand USD | 0.0% |
| 2021 Q4 | -210.06 Thousand USD | 0.0% |
| 2021 FY | -367.59 Thousand EUR | -15.16% |
| 2020 FY | -319.19 Thousand EUR | -8.85% |
| 2020 Q4 | -172.32 Thousand USD | 0.0% |
| 2020 Q2 | -147.59 Thousand USD | 0.0% |
| 2019 Q4 | -148.67 Thousand USD | 0.0% |
| 2019 FY | -293.24 Thousand USD | -9.5% |
| 2018 FY | -267.8 Thousand USD | -16.39% |
| 2017 FY | -230.09 Thousand USD | -24.56% |
| 2016 FY | -184.73 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.674% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -151.325% |
| Qrons Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 554.803% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 106.86% |
| BioStem Technologies, Inc. | 15.42 Million USD | 105.206% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -546.272% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -1563.938% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.011% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 96.887% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 108.355% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 671.53% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -32823.329% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 105.354% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 25986.525% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 108.199% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 1321.702% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -2251.391% |
| Mesoblast Limited | -35.16 Million USD | 97.717% |
| Marizyme, Inc. | 457.7 Thousand USD | 275.442% |
| Genus plc | 178.7 Million USD | 100.449% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.365% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 1390.457% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 295.775% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -7200.0% |
| ContraFect Corporation | -154 Thousand USD | -421.429% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -1506.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 1146.104% |
| IMV Inc. | -962.29 Thousand USD | 16.554% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -107.225% |
| MultiCell Technologies, Inc. | 49.32 USD | 1628242.741% |
| ONE Bio Corp. | 20.12 Million USD | 103.99% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 101.994% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 1742.127% |
| Q BioMed Inc. | -8988.00 USD | -8834.134% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 102.842% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -5106.172% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 101.81% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 29.658% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 1247.143% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -16115.67% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -723.463% |
| GB Sciences, Inc. | -624.00 USD | -128585.897% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -833.417% |
| HST Global, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -385957.692% |
| Enzolytics Inc. | 30.7 Thousand USD | 2714.954% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 266.448% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.072% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -56.071% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 230.065% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.196% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -8967.299% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -857.674% |
| Kadimastem Ltd | -630.13 Thousand USD | -27.432% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 181.277% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -6684.96% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 554.803% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 159.168% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -2668.966% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 278.427% |
| SYBLEU INC | 11.69 Thousand USD | 6965.595% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 117.426% |
| Bioxytran, Inc. | -8285.00 USD | -9592.215% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -115.282% |
| Neutra Corp. | 14.33 Thousand USD | 5701.674% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -879.268% |
| PureTech Health plc | -1.6 Million USD | 49.906% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 19.799% |
| IXICO plc | 3.27 Million USD | 124.557% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -15.706% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 55.165% |
| CSL Limited | 7.7 Billion USD | 100.01% |
| Cellectis S.A. | 18 Thousand USD | 4561.111% |